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Platelet endothelial cell adhesion molecule (PECAM)
is used extensively as a murine vascular marker. PE-
CAM interactions have been implicated in both vascu-
logenesis and angiogenesis. To better understand the
role of PECAM in mammalian development, PECAM
expression was investigated during differentiation of
murine embryonic stem (ES) cells and in early mouse
embryos. Undifferentiated ES cells express PECAM,
and as in vitro differentiation proceeds previously
unidentified PECAM-positive cells that are distinct
from vascular endothelial cells appear. PECAM ex-
pression is gradually restricted to endothelial cells
and some hematopoietic cells of differentiated blood
islands. In embryos, the preimplantation blastocyst
contains PECAM-positive cells. PECAM expression is
next documented in the postimplantation embryonic
yolk sac, where clumps of mesodermal cells express
PECAM before the development of mature blood is-
lands. The patterns of PECAM expression suggest that
undifferentiated cells, a prevascular cell type, and
vascular endothelial cells express this marker during
murine development. PECAM expression in blasto-
cysts and by ES cells suggests that PECAM may func-
tion outside the vascular/hematopoietic lineage.
(Am J Pathol 1999, 154:1137–1147)
Platelet endothelial cell adhesion molecule (PECAM) is a
member of the immunoglobulin superfamily expressed
by endothelial cells and a subset of hematopoietic cells in
the adult organism.1–3 PECAM is localized to the cell-cell
borders of the vascular endothelial cell where it mediates
the extravasation of monocytes and neutrophils during
the inflammatory response.4,5 PECAM engagement can
also result in an up-regulation of integrin function in a
variety of hematopoietic cells.6–10 During platelet aggre-
gation, PECAM becomes phosphorylated on tyrosine.11
Phosphorylated PECAM can then associate with SHP-2, a
positive regulator of signal transduction, suggesting that
PECAM may participate in a signaling cascade that re-
sults in integrin activation.
PECAM is expressed in the mouse embryo before the
need for the inflammatory response, and it is used exten-
sively as a developmental murine vascular marker.12,13
Recently, PECAM phosphorylation during embryonic
vasculogenesis was documented,14 suggesting a possi-
ble signaling role for PECAM in blood vessel formation.
PECAM interactions are also implicated in angiogenesis,
the sprouting of new vessels from a pre-existing vascular
tree.1 In postimplantation embryos PECAM is first de-
tected in precursor cells of yolk sac blood islands at day
7.5 and subsequently in the developing embryonic vas-
culature.14,15 The expression of PECAM by yolk sac pre-
cursors suggests that PECAM is involved in the earliest
steps of vasculogenesis, as the yolk sac is an early site of
both vascular and hematopoietic development in mam-
mals.16,17
Murine embryonic stem (ES) cells are derived from the
inner cell mass of blastocysts and are totipotent. ES cells
differentiated in culture undergo a programed differenti-
ation that recapitulates normal developmental events in
the yolk sac, including vascular and hematopoietic de-
velopment.18–23 The endothelial cells and some hemato-
poietic cells in ES cell differentiation cultures express
PECAM.24–26 It was recently reported that undifferenti-
ated ES cells express PECAM.27–29 Because ES cells
resemble the inner cell mass of the blastocyst, this sug-
gested that PECAM may be expressed embryonically
earlier than the described postimplantation stages.
To obtain a better understanding of the role of PECAM
in early mouse development, we examined PECAM ex-
pression in ES cells during a time course of differentiation
and in preimplantation and early postimplantation em-
bryos. To our surprise, PECAM was expressed continu-
ously during ES cell differentiation. In vivo, PECAM was
expressed by blastocysts and in postimplantation yolk
sacs, suggesting that PECAM functions outside the vas-
cular/hematopoietic system.
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The murine ES cell line, IE6/2, was maintained in an
undifferentiated state and differentiated as described,25
except that in some cases ES cells were plated directly
into tissue culture dishes. Briefly, ES cells were expanded
undifferentiated in medium containing 5637-cell condi-
tioned medium. For differentiation, cells were cultured for
6 to 7 days to allow the gradual depletion of LIF/DIA from
the culture medium. These cultures were then dissoci-
ated into clumps by treatment with Dispase (Boehringer
Mannheim, Indianapolis, IN) on day 0. The cell clumps
were either plated directly onto tissue culture dishes or
were incubated in suspension in Petri dishes for 3 days
before transfer to tissue culture dishes. The culture me-
dium was DMEM-H, 20% fetal calf serum (lot tested for
ability to support differentiation), 150 mmol/L a-thioglyc-
erol, and 50 mg/ml gentamicin. ES cells and differentia-
tion cultures were fixed for 7 minutes with either cold 50%
methanol/50% acetone (MA) or fresh 4% paraformalde-
hyde (PFA) and rinsed in phosphate-buffered saline
(PBS) before antibody staining.
Cell suspensions for immunostaining were treated with
0.2% collagenase (type II, Sigma, St. Louis, MO). After
enzyme treatment, the cells were triturated and then
washed with PBS to remove any remaining collagenase.
The cell suspension was then either fixed with 4% PFA,
then immunostained or first immunostained, then fixed.
Both methods yielded identical staining patterns.
For ES rescue experiments, ES cells were treated with
Dispase, then plated at a constant density onto multiple
duplicate plates and grown in differentiation conditions.
Cultures were dissociated with 0.2% collagenase on
days 1 to 8 of differentiation, and a duplicate culture was
fixed and immunostained for PECAM. After dissociation,
cell counts were determined using a hemocytometer and
a fixed number of cells was plated and grown in ES cell
culture conditions. The cultures were maintained for 4
days, with daily medium replenishment, then fixed and
scored for ES cell colonies. The PECAM staining pattern
was visually analyzed.
Mouse embryos were obtained from timed matings,
and day 0.5 was noon of the day the plug was observed.
Blastocysts were isolated by flushing dissected uteri with
PBS on day 3.5 followed by overnight fixation with 4%
PFA at 4°C. Postimplantation embryos were dissected
from the uterus and immediately fixed in cold 4% PFA.
After 24 hours, the embryos were dehydrated through a
methanol series and stored at 220°C in 100% methanol.
Reverse Transcription-Polymerase Chain
Reaction
Total RNA was prepared from ES cells and differentiation
cultures by the method of Chomczynski and Sacchi.30
PolyA1 RNA was prepared from approximately 65 blas-
tocysts using guanidinium thiocyanate disruption fol-
lowed by oligo(dT)-cellulose chromatography (Quick
Prep Micro, Pharmacia, Piscataway, NJ). Either this
polyA1 RNA or 5 mg of total RNA from cultured cells was
reverse transcribed using random primers and Super-
script II (Life Technologies, Gaithersburg, MD), as rec-
ommended by the manufacturer. The resulting cDNAs
were amplified by the polymerase chain reaction (PCR).
Cycling conditions were: 94°C, 45 seconds; 55°C, 1
minute, 15 seconds; 72°C, 2 minutes for 35 cycles, fol-
lowed by a 15-minute incubation at 72°C. The primers
used were PECAM 5.1, nucleotides 1704–1723, 59-
CAAGCGGTCGTGAATGACAC-39; PECAM 3.1, nucleo-
tides 2278–2298, 59-CACTGCCTTGACTGTCTTAAG-39;
b-actin 1, nucleotides 950–971, 59-TACTGCTCTGGCTC-
CTAGCACC-39; and b-actin 2, nucleotides 1076–1096,
59-CCGGACTCATCGTACTCCTGC-39. Products of PCR
reactions were analyzed on 7% polyacrylamide gels.
Immunolocalization
Antibody staining was performed as described.24,25 The
following antibodies were used, with the fixation methods
and working dilutions in parentheses: purified rat anti-
mouse PECAM antibody Mec 13.3 (PFA or MA, 0.5 mg/
ml), purified rat anti-mouse CD34 antibody RAM34 (PFA,
1 mg/ml) (PharMingen, San Diego, CA), purified rat anti-
mouse PECAM antibody EA-3 (MA, 1.5 mg/ml), affinity-
purified rabbit anti-mouse PECAM antibody (PFA,
1:1000) (both kind gifts of Beat Imhof), and affinity-puri-
fied mouse anti-mouse SSEA-1 antibody MC-480 (PFA,
29 ng/ml) (Developmental Studies Hybridoma Bank, Iowa
City, IA). The anti-PECAM antibody Mec 13.3 was also
biotinylated for use in double staining (PFA, 0.5 mg/ml).
After blocking with 5% fetal calf serum for 1 hour, cultures
were incubated with primary antibodies at 37°C for 1
hour. Blastocysts were incubated in 5 mg/ml Mec 13.3 or
15 mg/ml EA-3 overnight at 4°C.
After washing in 5% fetal calf serum, cultures were
incubated with secondary antibodies for 45 to 60 minutes
at 37°C. Detection of rat monoclonal antibodies was with
B-phycoerythrin-conjugated goat anti-rat IgG (1:1000), B-
phycoerythrin-conjugated donkey anti-rat IgG (1:1000), or
FITC-conjugated donkey anti-rat IgG (15 mg/ml), SSEA-1
was visualized using B-phycoerythrin-conjugated goat
anti-mouse IgM (1:500) (Jackson Immunoresearch, West
Grove, PA). Biotinylated Mec 13.3 and the PECAM anti-
serum were visualized using R-PE-labeled streptavidin
(0.5 mg/ml) and FITC-conjugated goat anti-rabbit sec-
ondary antibody (2 mg/ml), respectively (Southern Bio-
technology Associates, Inc., Birmingham, AL). Blasto-
cysts were incubated with a 1:100 dilution of the
B-phycoerythrin-conjugated goat anti-mouse secondary
antibody overnight at 4°C. As controls, cultures and em-
bryos were also incubated with secondary antibody
alone and with an isotype-matched rat anti-mouse IgE
FcR antibody (B3B4, PharMingen) detected with an anti-
rat secondary antibody. Purified mouse IgM, k subtype,
was used in conjunction with the anti-mouse IgM second-
ary antibody as a control for SSEA-1 staining. Staining
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was visualized with an Olympus IX50 microscope
equipped with phase contrast and epifluorescence op-
tics and an Olympus PM-30 camera.
Postimplantation embryos were stained as described
by Kispert and Herrmann31 with some modifications.
Most incubations were performed using embryos placed
in nets (Costar 3477) that fit into the wells of 12-well
dishes along with 2 ml of each reagent. All incubations
were at room temperature on a rocking platform unless
otherwise noted. PFA-fixed embryos that were stored in
100% methanol at 220°C were rehydrated in PBS for 30
minutes. Free aldehyde groups were blocked in 1 mol/L
glycine, pH 7–8, for 30 minutes, and embryos were then
washed in PBS for 30 minutes. Embryos were next incu-
bated in 6% H2O2 in PBS for 25 minutes to block endog-
enous peroxidases, and washed in three changes of PBT
(PBS plus 0.1% Tween 20) for 5 minutes each. Embryos
were incubated in 10 mg/ml proteinase K in PBS for 3 to
5 minutes (depending on size), and washed in 2 mg/ml
glycine. Embryos were washed in three changes of PBT
for 5 minutes each, then in PBTN (PBT plus 5% heat-
inactivated fetal calf serum) for 30 minutes. Primary anti-
body was rat anti-mouse PECAM (Mec 13.3, Pharmin-
gen) diluted to 1:200 in PBTN, and embryos were
incubated overnight at 4°C with rocking. The next day,
embryos were washed in PBT three times for 5 minutes
each, then three times for 30 minutes each, then washed
in PBTN for 30 minutes. Secondary antibody was goat
anti-rat horseradish peroxidase (Accurate, IgG (H1L)),
diluted to 1:200 in PBTN, and embryos were incubated
overnight at 4°C with rocking. The next day embryos were
washed in PBT three times for 5 minutes each, four times
for 25 minutes each, then transferred to a glass watch
dish. Embryos were incubated in a mixture of 0.3 mg/ml
3,39-diaminobenzidine and 3 mg/ml NiSO4 in PBT in the
dark for 10 minutes, then incubated with the same mix-
ture plus H2O2 at 1:1000 dilution. After development (3
minutes for smaller embryos, 5 minutes for larger embry-
os), the reaction was stopped by washing in PBS 3 times
for 5 minutes each. Embryos were photographed using a
Nikon SMZ-U stereomicroscope. Embryos were embed-
ded in paraffin, and 8-mm sections were cut and mounted
using DPX mounting medium (Fluka). Sections were pho-
tographed using a Nikon Optiphot-2 microscope outfitted
with DIC optics.
Results
PECAM Expression in ES Cells
To verify that ES cells expressed PECAM,27–29 ES cells
were fixed either 3 or 6 days after plating and stained with
an anti-PECAM antibody. As expected, a majority of the
Figure 1. Immunofluorescence of ES cell clumps with an anti-PECAM antibody. ES cells were incubated with the anti-PECAM antibody Mec 13.3 (A and C) or an
isotype-matched anti-IgE FcR control antibody (B and D), followed by detection with a B-phycoerythrin-conjugated secondary antibody. Fluorescent (A, B) and
phase-contrast (C, D) images are shown. Scale bar, 30 mm.
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ES cells expressed PECAM, and expression was local-
ized to cell-cell boundaries (Figure 1). To further charac-
terize the stained ES cells, cultures were enzymatically
dissociated and double stained for PECAM and SSEA-1
(Figure 2), since SSEA-1 has been used as a marker of
undifferentiated and partially differentiated embryonic
cells.32–34 The majority of the cells stained for both anti-
bodies (Figure 2, C and F), although rare cells stained for
either PECAM or SSEA-1. This finding shows that the
PECAM1 cells in ES cell cultures also express SSEA-1,
which suggests that the cells are either undifferentiated
ES cells or partially differentiated ES cell derivatives.
PECAM Expression during ES Cell
Differentiation
To determine the relationship between the PECAM ex-
pression seen on ES cells and in vascular endothelium,
RNA analysis was done on a time course of ES cell
differentiation. Reverse transcription-PCR of RNA from
both ES cells and differentiation cultures from days 1 to 7
showed that a band of the predicted size was amplified
with PECAM primers from all of the cultures (Figure 3).
This finding suggested that PECAM was expressed
throughout the differentiation time course.
Immunofluorescence analysis was used to localize
PECAM expression during ES cell differentiation (Figures
4 and 6B). PECAM was expressed throughout the time
course. The widespread staining pattern seen in ES cells
was restricted in day 2 cultures, and large areas of un-
stained cells were interspersed between small clumps of
PECAM1 cells, in addition to ES-like balls of PECAM1
cells (Figure 4A and data not shown). On day 4 of differ-
entiation the pattern was similar to day 2, except that the
Figure 2. Immunofluorescence of dissociated ES cells. ES cell cultures were treated with collagenase and then incubated with the following antibodies or sets of
antibodies: (A, D), anti-PECAM antiserum and mouse IgM control; (B, E), mouse anti-SSEA-1, (C, F), anti-PECAM antiserum and mouse anti-SSEA-1. Secondary
antibodies were goat anti-rabbit FITC (green) and donkey anti-mouse B-phycoerythrin (red). A–C: FITC fluorescence; D–F: B-phycoerythrin fluorescence. Scale
bar, 60 mm.
Figure 3. PECAM RNA analysis of ES cell differentiation. Total RNA was
reverse transcribed using random primers and then amplified using either
PECAM (A) or b-actin (B) primers. Lane 1, ES cells; lanes 2–8, days 1–7 of
differentiation; lane 9, 3T3 fibroblasts. The predicted sizes of the PECAM and
b-actin products are 215 and 147 bp, respectively. The positions of molecular
weight standards are indicated to the right of each gel.
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ES-like PECAM1 balls decreased and the clumps of PE-
CAM1 cells became more well defined (Figures 4B and
6B). On day 6, cords of PECAM1 cells were evident that
were morphologically distinct from PECAM1 blood ves-
sels that are present at later days (compare Figures 4C
and 4G). On day 8 the PECAM1 cells were organized into
blood vessels and small lacunae began to form (Figures
4G and 6B). By day 10 the blood vessels increased in
size and formed blood islands in some areas, although
areas of vascular plexus were also evident (Figure 4H).
The blood islands and vascular plexus persisted through
day 12 (Figure 4I), then became less well defined with
further time in culture (data not shown). In all cases, the
PECAM staining was localized to cell-cell boundaries.
CD34 Is Expressed Subsequent to PECAM
during ES Cell Differentiation
Because the PECAM staining seen on days 0–6 of the
time course was not associated with patent blood ves-
Figure 4. PECAM immunofluorescence of ES cell differentiation. Dispase-treated ES cells were plated onto tissue culture dishes on day 0. Representative plates
were fixed every other day. Wells were stained with an anti-PECAM antibody and a B-phycoerythrin-conjugated secondary antibody. A, D: day 2; B, E: day 4;
C, F: day 6; G, J: day 8; H, K: day 10; I, J: day 12. A–C, G–I: fluorescence photomicrograph; D–F, J–L: the corresponding phase contrast photomicrograph.
Arrowheads in H point to PECAM strain at cell borders. Scale bar, 30 mm.
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Figure 5. Double immunofluorescence for PECAM and CD34 in ES cells and during ES cell differentiation.
A, F: undifferentiated ES cells, fixed 3 days after passage. B–E, G–J: Dispase-treated ES cells were
cultured in Petri dishes for 3 days, then plated onto tissue culture dishes. Representative plates were fixed
every day, beginning with day 5. Wells were stained with biotin-conjugated Mec 13.3 (A–C, E) and an
anti-CD34 rat monoclonal antibody (F–I). Control plates had either the anti-PECAM primary antibody (D)
or the anti-CD34 antibody primary antibody (J) omitted. Detection was with streptavidin-conjugated
B-phycoerythrin and donkey anti-rat FITC. A, F, undifferentiated ES cells; B, G, day 6; C–E, H–J, day 10.
A–E, PECAM-specific B-phycoerythrin fluorescence; F–J, CD34-specific FITC fluorescence of the same
wells. In B and G, the arrow shows cells that are CD34-negative and PECAM-positive and the arrowhead
indicates cells that are double positive.
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sels, a second vascular marker was used in conjunction
with PECAM to determine the expression profile of non-
vessel PECAM1 cells. CD34 is a surface marker of vas-
cular endothelium that is expressed during embryonic
development.35 Unlike PECAM, CD34 is not expressed
on undifferentiated ES cells (Figure 5F). Both PECAM and
CD34 are expressed in the vessels of a differentiated
culture at day 10. (Figure 5, C and H). In contrast, at day
6 of differentiation, some of the newly formed vessels are
stained for both PECAM and CD34 (arrowhead in Figure
5, B and G), while the tips of other vessels are PECAM-
positive but CD34-negative (arrow in Figure 5, B and G).
On day 10, a few round cells within the blood islands
(Figure 5, C and H) and a smaller number of round cells
adjacent to the blood islands (data not shown) are CD34/
PECAM double positive. Because CD34 also stains a
subset of hematopoietic cells within the developing yolk
sac in vivo,36 these CD341 cells are most likely hemato-
poietic cells.
ES Colony Recovery from Differentiating
Cultures
Although the PECAM1 cells seen in clumps or cords on
day 6 of differentiation are distinguished from mature
blood island endothelial cells by lack of expression of
CD34, they are not distinguished from ES cells by the
markers used in our study. To further delineate the rela-
tionship between the PECAM1 clumps of cells and ES
colony-forming potential, a time course of differentiation
was analyzed for both PECAM staining pattern and ES
colony recovery (Figure 6). As expected, the number of
ES colonies recovered from plating differentiation culture
cells in ES culture conditions decreased with differentia-
tion time (Figure 6A). A significant drop in the percentage
was seen between days 3 and 4, and from day 4 to day
8 the percentage of ES colonies recovered remained
fairly constant. In contrast, the PECAM1 clumps were first
evident on day 2 of duplicate culture plates, and their
presence remained fairly constant through day 6 (Figure
6B), although they assumed more “vessel-like” arrange-
ments with time (compare Figures 4A and 4G). Signifi-
cantly, the appearance of vessels between days 6 and 7
was accompanied by a decrease in the relative area
covered by the PECAM1 clumps, suggesting a possible
precursor relationship between the PECAM1 clumps and
blood islands. Moreover, the functional assay for ES col-
ony forming potential has a different temporal pattern
than the clumps of PECAM1 cells, suggesting that the
PECAM1 cells are not ES cells.
Figure 6. A time course of ES colony recovery and PECAM immunostaining.
ES cells were treated with Dispase and cultured in differentiation medium.
Each day 2 sets of dishes were either fixed and stained for PECAM or treated
with collagenase and replated for ES colony formation. A: ES colonies were
counted 4 days after plating either 200,000 or 500,000 cells treated with
collagenase and their number calculated as a percent of maximum colony
number. B: Parallel cultures were visually examined and the relative amount
of PECAM staining in three patterns was assessed: balls, tight clumps of cells
with a dense staining pattern, similar to Figure 1A (ES-like); clumps, small to
medium aggregations of cells with distinct cell border staining, similar to
Figure 4, A–C; vessels, cells arranged with continuous staining at cell-cell
borders, similar to Figure 4, G–I. The area covered by each pattern of staining
was estimated as follows: 6, trace; 1, 2–5%; 11, 5–10%; 111, 10–30%;
1111, .30%.
Figure 7. PECAM RNA analysis of mouse blastocysts. Poly A1 RNA (blasto-
cysts) or total RNA (cell lines) was reverse transcribed using random primers,
then amplified using either b-actin (lanes 1–3) or PECAM (lanes 4–6)
primers. Lanes 1, 4: blastocysts; lanes 2, 5: Py-4–1 endothelial cells; lanes
3, 6: 3T3 fibroblasts. The predicted sizes of the PECAM and b-actin products
are 215 and 147 bp, respectively. The positions of molecular weight stan-
dards are indicated in the right margin.
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PECAM Expression in Mouse Blastocysts
To determine whether the PECAM expression seen in ES
cell cultures recapitulates expression during embryonic
development, RNA from blastocysts was analyzed by
reverse transcription-PCR for PECAM expression (Figure
7). PolyA1 RNA from a pool of blastocysts produced a
band of the appropriate size when amplified with PECAM
primers. Individual blastocysts were then analyzed by
immunofluorescence to localize PECAM expression (Fig-
ure 8). Two different PECAM antibodies showed similar
patterns, with staining localized to cell-cell junctions. The
patterns suggested that the inner cell mass, from which
ES cells are derived, may selectively express PECAM
protein, but the background of trophoblast cell reactivity
made definitive localization difficult.
PECAM Expression in Postimplantation
Embryos
In a previous study PECAM expression was detected in
angioblasts on day 7.5 in the developing yolk sac.14
Because PECAM is expressed before overt vasculariza-
tion during ES cell differentiation, we examined embryos
from early postimplantation stages to confirm that
PECAM was expressed before the development of ma-
ture endothelial cells. Both whole mount in situ hybridiza-
tion with a PECAM probe and immunofluorescence of
sectioned embryos with an anti-PECAM antibody failed to
detect PECAM expression in egg cylinder to early prim-
itive streak stage embryos (data not shown). Both
PECAM RNA and PECAM protein were detected in the
developing yolk sac of mid-streak stage embryos (Figure
9 and data not shown). Sectioning of the antibody-
stained embryos showed that PECAM was expressed in
clumps of mesodermal cells before the detection of ma-
ture endothelial cells (Figure 9, B–D). The PECAM1 cells
in the yolk sac in vivo resemble in morphology and tem-
poral sequence the PECAM1 cell clumps seen during ES
cell differentiation, suggesting that an in vivo counterpart
of the PECAM1 clumps of cells does exist.
Discussion
The lack of definition regarding pre-endothelial stages of
mouse vascular development, coupled with lack of
knowledge of the precise expression pattern of the vas-
cular cell adhesion molecule PECAM, led us to examine
PECAM expression during ES cell differentiation and in
early mouse embryos. We confirmed that undifferentiated
ES cells express PECAM, and we showed for the first time
that this early expression mirrors PECAM expression in
the mouse blastocyst. PECAM is expressed continuously
Figure 8. PECAM immunofluorescence of mouse blastocysts. Fixed blastocysts were stained with a control antibody directed against IgE FcR (A, D) or two
different anti-PECAM antibodies, Mec13.3 (B, E) or EA-3 (C, F), followed by detection with a goat anti-rat B-phycoerythrin secondary antibody. A–C: fluorescent
photomicrographs; D–F: the corresponding phase-contrast micrographs. Scale bar, 25 mm.
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during ES cell differentiation and characterizes a popu-
lation of cells that are PECAM1 but not part of patent
blood vessels. These cells have a possible counterpart in
vivo in the yolk sac mesodermal cells that express
PECAM before blood island formation. These findings are
consistent with the model that ES cell differentiation re-
capitulates yolk sac development.18,22
Undifferentiated ES cells express PECAM,27–29 and we
confirmed this finding using double immunofluorescence
analysis with PECAM and SSEA-1, a marker of undiffer-
entiated and partially differentiated embryonic cells.32–34
PECAM expression in ES cells is not an artifact of tissue
culture, since cells of the mouse blastocyst also express
PECAM. This early expression of the PECAM gene during
development is also suggested by the report of a PECAM
promoter-driven cre transgene.37 The ubiquitous excision
of the loxP-flanked VCAM-1 target allele indicates that the
PECAM gene is expressed early in development, consis-
tent with the blastocyst expression that we have ob-
served. Moreover, PECAM is localized to cell-cell borders
in ES cells and blastocysts, suggesting that it may play a
role in cell adhesion or transmembrane signaling at this
early stage.38–42 However, it is unlikely that PECAM is
involved in intercellular migration at this early stage of
development, since no cellular migration into the blasto-
cele cavity is known to occur at this time.
To our surprise, PECAM was expressed continuously
throughout ES cell differentiation. Although many vascu-
lar markers are also expressed in other lineages, contin-
uous expression of a single marker from uncommitted
cells through differentiated endothelium has not been
observed. This result also differs from the findings of
Vittet et al,27 who describe a PECAM-negative stage as
ES cells begin to differentiate. However, Ling and
Neben29 documented expression of PECAM (named
ER-MP12) throughout ES cell differentiation using FACS
analysis. In our study using immunofluorescence,
PECAM was initially expressed in all or most ES cells, but
after several days of differentiation most cells did not
express PECAM. The remaining PECAM1 cells were
found in small clumps that were morphologically distinct
from the blood islands that form at later times.
The expression of other vascular markers also distin-
guishes early PECAM1 cells from later PECAM1 endo-
thelial cells. The early PECAM1 cells do not express
CD34, which is expressed by all blood island endothelial
cells and a subset of hematopoietic cells (Ref. 36; this
report). The early PECAM1 cells also do not express
ICAM-2, which is expressed by all patent vessels and
blood islands that are PECAM1 at later stages (M. Har-
maty, M. Inamdar, and V. L. Bautch, unpublished obser-
vations). Preliminary results suggest that many of the
PECAM1 cells found at early stages of ES cell differenti-
ation express SSEA-1 (S. Redick and V. L. Bautch, un-
published observations), a marker of undifferentiated and
partially differentiated embryonic cells.33,43 SSEA-1 is not
expressed by PECAM1 endothelial cells in blood islands.
Thus the expression of PECAM during ES cell differenti-
ation may characterize an endothelial precursor that sub-
sequently matures to a blood island endothelial cell that
expresses CD34 and ICAM-2 in addition to PECAM. This
model is supported by time course analysis of ES colony
recovery and PECAM staining that shows distinct tempo-
ral patterns for PECAM1 clumps and ES colony potential,
suggesting that at least a subset of PECAM1 cells
present before vessel formation are not ES cells. A pre-
Figure 9. Whole-mount PECAM antibody staining of postimplantation em-
bryos. E 7.5 embryos (mid-streak to early head fold stage) were subjected to
whole-mount antibody staining with Mec 13.3 rat anti-mouse PECAM anti-
body (A). Embryos were then embedded in paraffin and sectioned (B–D). B:
cross-section through the yolk sac and allantois of a mid-streak embryo.
PECAM staining is seen at the cell borders of a clump of mesodermal cells
that, by position, will form a blood island. Additional PECAM reactivity is
seen in a small clump closer to the embryonic/extraembryonic border
(arrowhead) and in a subset of cells within the allantois (arrows) that are
likely to be endothelial precursors. C: another clump of PECAM1 yolk sac
mesodermal cells from the same embryo. D: a clump of mesodermal yolk sac
cells from a slightly older embryo, with a mixture of PECAM1 and PECAM-
negative cells (arrow).
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cursor relationship is also suggested by a decrease in
PECAM1 cell clumps that accompanies vessel formation
during ES cell differentiation. Likewise, analysis of mutant
ES cells that do not express VEGF shows that relatively
large numbers of the early PECAM1 cells accumulate,
concomitant with severely reduced numbers of blood
islands (V. L. Bautch, S. Redick, A. Scalia, P. Carmeliet,
and R. Rapoport, manuscript in preparation).
The in vivo analysis was consistent with reported anal-
yses14,15 that first detected PECAM expressing cells in
the developing yolk sac of day 7.0 to 7.5 embryos, at or
just before blood island formation. Our detailed analysis
confirms that clumps of yolk sac mesodermal cells ex-
press PECAM before the development of morphologically
distinct endothelial and hematopoietic cells. This finding
suggests that yolk sac vascular/hematopoietic precur-
sors express PECAM. Some PECAM1 cells are also
found in the developing allantois, which is consistent with
a recent report that the murine allantois has high vascular
potential.44 Postimplantation embryonic PECAM expres-
sion is first seen slightly later in the lateral mesoderm
where the dorsal aorta will form (Refs. 14, 15; V. L.
Bautch, unpublished observations). Taken together,
these expression patterns suggest that PECAM expres-
sion after the blastocyst stage is confined to cells and/or
precursors of the vascular/hematopoietic lineages. More-
over, if a common precursor of both lineages called the
hemangioblast exists, it is likely to express PECAM.
Because the PECAM1 nonvascular cells found just
before blood island formation in ES cell differentiation are
similar in morphology and temporal appearance to yolk
sac blood island precursor cells, it is possible that they
are the in vitro counterpart of the yolk sac precursor cells.
Several recent reports provide evidence that differentiat-
ing ES cells at early stages provide an environment con-
ducive to vascular/hematopoietic development. Blast col-
onies that apparently form from single vascular/
hematopoietic precursor cells peak early during in vitro
differentiation of ES cells.45 Up to half of the cells in early
embryoid bodies are positive for flk-1, a marker of early
vascular and hematopoietic cells.46 Differentiation of ES
cells mutant for flk-1 revealed an ability to form primitive
erythroid cells that was not seen when the same cells
were analyzed in chimeras.47 One explanation of the data
were that ES cell differentiation provided yolk sac-derived
signals to mesodermal cells without a concomitant re-
quirement for migration, and these signals promoted he-
matopoietic differentiation. Thus ES cell differentiation
appears to recapitulate the early yolk sac environment
and early vascular development. Fortunately, the acces-
sibility of the PECAM1 ES-derived cells should allow fur-
ther characterization of mammalian vascular develop-
ment with lineage markers as well as functional studies of
purified cells.
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